Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 16, 2020 - Issue 11
Submit an article Journal homepage
2,211
Views
6
CrossRef citations to date
0
Altmetric
Review

Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine in patients with immunocompromising conditions: a review of available evidence

Erica Chilsona Vaccine Medical Development & Scientific/Clinical Affairs, Pfizer Inc, Collegeville, PA, USACorrespondence[email protected]
View further author information
,
Daniel A. Scottb Vaccine Clinical Research and Development, Pfizer Inc, Collegeville, PA, USAORCID Iconhttps://orcid.org/0000-0002-4916-145XView further author information
ORCID Icon,
Beate Schmoele-Thomac Vaccine Clinical Research and Development, Pfizer Pharma GmbH, Berlin, GermanyORCID Iconhttps://orcid.org/0000-0003-4632-357XView further author information
ORCID Icon,
Wendy Watsonb Vaccine Clinical Research and Development, Pfizer Inc, Collegeville, PA, USAView further author information
,
Mary M. Morana Vaccine Medical Development & Scientific/Clinical Affairs, Pfizer Inc, Collegeville, PA, USAView further author information
&
Raul Isturiza Vaccine Medical Development & Scientific/Clinical Affairs, Pfizer Inc, Collegeville, PA, USAView further author information
Pages 2758-2772 | Received 28 Oct 2019, Accepted 21 Feb 2020, Published online: 12 Jun 2020

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Yu Hu, Xuejiao Pan, Fuxing Chen, Ying Wang, Hui Liang, Linzhi Shen, Yaping Chen & Huakun Lv. (2022) Surveillance of adverse events following immunization of 13-valent pneumococcal conjugate vaccine among infants, in Zhejiang province, China. Human Vaccines & Immunotherapeutics 18:1.
Read now

Articles from other publishers (5)

Elsemieke te Linde, Laura Doornekamp, Katrijn C. P. Daenen, Eric C. M. van Gorp & Anke H. W. Bruns. (2023) Dutch Healthcare Professionals’ Opinion on the Allocation of Responsibilities concerning Prescribing and Administering Medically Indicated Vaccines to Immunocompromised Patients. Vaccines 11:3, pages 686.
Crossref
Brandon Essink, Charu Sabharwal, Kevin Cannon, Robert Frenck, Himal Lal, Xia Xu, Vani Sundaraiyer, Yahong Peng, Lisa Moyer, Michael W Pride, Ingrid L Scully, Kathrin U Jansen, William C Gruber, Daniel A Scott & Wendy Watson. (2022) Pivotal Phase 3 Randomized Clinical Trial of the Safety, Tolerability, and Immunogenicity of 20-Valent Pneumococcal Conjugate Vaccine in Adults Aged ≥18 Years. Clinical Infectious Diseases 75:3, pages 390-398.
Crossref
Bharat Kumar, Samuel Zetumer, Melissa Swee, Ellen L Keyser Endelman, Manish Suneja & Benjamin Davis. (2022) Reducing Delays in Diagnosing Primary Immunodeficiency Through the Development and Implementation of a Clinical Decision Support Tool: Protocol for a Quality Improvement Project. JMIR Research Protocols 11:1, pages e32635.
Crossref
Claire Froneman, Peter Kelleher & Ricardo J. José. (2021) Pneumococcal Vaccination in Immunocompromised Hosts: An Update. Vaccines 9:6, pages 536.
Crossref
Federico Javier Ortiz-Ibarra, Luis Xochihua Díaz, Napoleón González Saldaña, Juana del Carmen Chacón Sánchez, Antonio Luévanos Velázquez, Francisco Javier Otero Mendoza, Mariana Merlo Palomera, Brandon Ortiz-Casas, Nideshda Ramírez Uribe, Enrique Rodríguez Barragán, Guillermo Hideo Wakida Kusunoki, Germán Camacho-Moreno & Francisco Espinosa Rosales. (2021) Inmunización con vacuna conjugada de neumococo y otras vacunas recomendadas en pacientes pediátricos de alto riesgo. Revista Latinoamericana de Infectología Pediátrica 34:4, pages 162-176.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.